This item is authorised by the following title:
For a transitional provision relating to the repeal of this instrument, see section 38 of the National Health (Highly Specialised Drugs Program) Special Arrangement 2021 (PB 27 of 2021).
sch 5 (item 1) of the National Health (Highly Specialised Drugs Program) Special Arrangement 2021
s 50 of the Legislation Act 2003
When documents are presented to the Australian Parliament for scrutiny, they are said to have been tabled.
For a transitional provision relating to the repeal of this instrument, see section 38 of the National Health (Highly Specialised Drugs Program) Special Arrangement 2021 (PB 27 of 2021).